After a thorough and inclusive evaluation process, Dr. Wright’s team at Atrium concluded that Medela NPWT pumps offer a critical combination of both optimized clinical outcomes and significant cost savings.
First and foremost, the Medela NPWT systems must deliver excellent clinical performance. The committee review found the systems to be proven and versatile systems that offer clinical flexibility with choice of pressure settings and therapy modes. Beyond the clinical performance, the review team found particular value in Medela’s unique capitated rate business model, which eliminates daily rental fees associated with NPWT devices in favor of a predictable fixed annual rate that is paid monthly. Dr. Wright and her team identified 3 key advantages linked to the model that can help Atrium—or any health system—innovate NPWT care.
